News Strategy for post-Brexit life science sector unveiled Plan aims to solve long-standing issue of access to medicines
News New funding to improve NHS tech adoption New £86 million fund aims to speed up patient access to innovative digital technologies.
News Disappointment as government delays pharma-friendly policies Proposals fall short of ambitions of Accelerated Access Review.
News UK must draw up post-Brexit pharma strategy Big pharma could take its money elsewhere post Brexit, report warns.
News Big pharma could leave UK - AZ's Pangalos Last week saw the publication of the UK's Accelerated Access Review, containing proposals to cut four years from the drug development process – but AstraZeneca seems unconvinced that access
News UK aims to cut four years from drug development process NICE, regulator and NHS should work together, according to review.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
